MedPath

Assessment of cardiac sarcoidosis by using PET tracer 18F-FMISO that accumulates in hypoxic tissues

Not Applicable
Conditions
cardiac sarcoidosis
Registration Number
JPRN-UMIN000031988
Lead Sponsor
Hokkaido University Hospital
Brief Summary

Eleven patients suspected or diagnosed as CS have been enrolled in this study since April 2018. All patients underwent FMISO PET and FDG-PET within 10 days. Nine patients were diagnosed as CS with a focal myocardial FDG uptake. Of these 9 patients, 7 patients showed focal FMISO uptake consistent with FDG uptake and 2 patients did not show FMISO uptake. For the remaining two patients who were not diagnosed as CS showed no significant FMISO accumulation in the myocardium.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
11
Inclusion Criteria

Not provided

Exclusion Criteria

Steroid therapy was initiated prior to the first scan.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath